The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Lower Call As AstraZeneca Earnings Slip

Fri, 18th May 2018 07:42

LONDON (Alliance News) - Stock prices in London are seen opening marginally lower on Friday after the FTSE 100 set a record closing high on Thursday, as AstraZeneca reported a drop in earnings for the first quarter. IG futures indicate the FTSE 100 index is to open down 4.77 points at 7,783.20. The blue chip index closed up 0.7% at 7,787.97 on Thursday.In early corporate news, Anglo-Swedish drugmaker AstraZeneca said its performance in product sales benefited from strong launches and continued growth of newer medicines in China, but was hurt by lower sales of its cholesterol drug Crestor due to generic competition. For the quarter ending March 31, revenue was down 4.0% to USD5.18 billion from USD5.40 billion in the first quarter last year. Product sales rose 3% at actual exchange rates to USD4.98 billion, but the group added that product sales growth this year is weighted to the second half.Pretax profit declined 36% USD374 million against USD582 million. "AstraZeneca's pipeline continued to bring significant benefits for patients, most recently with the expanded US approval of Tagrisso for lung cancer and Lynparza for breast cancer. With our transformation coming into sharper commercial focus as the year progresses, we are confident of delivering on our goals," said Chief Executive Pascal Soriot. Jordan-founded generic drugmaker Hikma Pharmaceuticals said it has made an encouraging start to the year, with its Global Injectables unit performing well, The division was supported by six product launches in the year, and "strong quality track record enabling to meet increased demand across our marketed portfolio", the company added. "Our efforts to reduce costs across the group are on track and we continue to focus on enhancing and investing in our pipeline. Our cash position remains very healthy and our balance sheet is strong. Altogether, these factors reinforce our positive outlook for the Group and enable us to reiterate our guidance for the full year," said CEO Siggi Olafsson.Oil companies BP and ConocoPhillips are in discussions for an asset swap deal that would see the UK energy major gain a greater foothold in a key project in the North Sea and the US explorer get Alaskan assets, the Bloomberg reported citing people familiar with the matter.BP is considering taking Conoco's stake in the Clair field, in which BP already holds a 28.6% stake and is the operator, according to the financial news service. BP describes Clair as "the largest undeveloped hydrocarbon resource" in the UK.Elsewhere, Unite Group said Property Director Richard Simpson will leave the student accommodation developer to take the CEO role at student accommodation builder Watkin Jones. Simpson will remain with Unite until December and take up his new position at Watkin Jones in January. Ophir Energy said CEO Nick Cooper has stepped down effective immediately, Non-Executive Director Alan Booth will assume the role of interim CEO until a replacement is found. "This decision to appoint a new CEO reflects the company's ongoing move to rebalance its portfolio towards a larger production and cash flow base, to support more focused and sustainable exploration activity," Ophir said. Sterling was flat quoted at USD1.3516 early Friday, versus USD1.3510 at the London equities close on Thursday.In the economic events calendar on Friday there is eurozone trade data at 1000 BST.In the US on Thursday, Wall Street ended lower, with the Dow Jones Industrial Average closing down 0.2%, S&P 500 down 0.1% and Nasdaq Composite ending 0.2% lower.Stocks in the US closed lower on Thursday as traders expressed some uncertainty about the second round of trade talks between the US and China.Blaming the trade policies of previous administrations, US President Donald Trump expressed some doubt about whether the high-level trade talks with China will be successful.Trump told reporters he tends to doubt the talks will be successful in remarks during an Oval Office meeting with NATO Secretary General Jens Stoltenberg."The reason I doubt it is because China has become very spoiled," Trump said. "The EU has become very spoiled. Other countries have become very spoiled, because they always got 100% of whatever they wanted from the US."The Japanese Nikkei 225 index closed up 0.3% Friday. In China, the Shanghai Composite is up 0.8%, while the Hang Seng index in Hong Kong is up 0.5%.In Asian economic news, nationwide consumer prices in Japan were up just 0.6% on year in April, the Ministry of Internal Affairs and Communications said. That was shy of expectations for a gain of 0.7% and was down sharply from 1.1% in March.Core CPI was up 0.7% on year, beneath forecasts for 0.8% and down from 0.9% in the previous month. On a monthly basis, overall CPI was down 0.4% and core CPI eased 0.1%.
More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.